


answers that enhance clinical insight
Clinicians receive clonoSEQ test results via an informative clinical report. These visually engaging reports provide clinicians with a clear MRD test result while also incorporating rich, quantitative data and comprehensive analysis for clinicians who want to dig deeper.



The Clonality (ID) Report provides an overview of the dominant DNA sequence(s) identified in a patient sample collected during diagnostic workup. These dominant sequences are typically associated with malignancy and will be used by the clonoSEQ Assay as the basis for MRD detection.
The Clonality (ID) Report is the first report that a clinician receives upon initiating clonoSEQ testing for a new patient.




The Tracking (MRD) Report summarizes results from MRD testing of patient samples collected during or after treatment. Tracking (MRD) Reports assess and quantify the presence of each tracked DNA sequence and identify newly emerging sequences associated with malignancy.
Since clinicians often assess MRD repeatedly during the course of a patient’s treatment or remission, many patients will receive multiple Tracking (MRD) Reports over time. Each report includes the results from previous reports, providing a visual representation of disease burden over time that clinicians can map to treatment cycles and easily communicate to patients.
All reports are delivered via a secure web portal, which provides convenient access to patient results when needed.
Log in to access your patients' clonoSEQ test results.

Dominant sequence(s) being tracked.

Clear result indicating whether residual disease was detected (Yes / No), and precise measurement of the level of residual disease.
Visual depiction of MRD results for all historically evaluated time points, making it easy for clinicians and patients to assess trends in disease burden over time.
|
An example clonoSEQ report.
Download a comprehensive guide to the reports that will walk you through each section in detail.
Adaptive’s Clinical Services and Medical Affairs teams provide clinicians with support throughout the clonoSEQ testing process and offer unmatched expertise in the field of MRD assessment. Their goal is to provide a seamless user experience, empowering clinicians with timely results that can inform their treatment decisions.
![]()